Meet Our Scientific Team

Dr. Etienne Sibille is co-founder and Chief Scientific Officer of Damona PharmaceuticalsTM


He is also a Senior Scientist in the Campbell Family Mental Health Research Institute and holds the Campbell Family Chair in Clinical Neuroscience at CAMH. Dr Sibille is also a Professor in the Department of Psychiatry and the Department of Pharmacology and Toxicology at the University of Toronto.

Dr. Sibille’s goals have consistently focused on translational research aimed at identifying the cellular and molecular bases of depression, specifically of the mood, affect and cognitive components of the illness in order to develop novel therapeutic avenues.


Dr. Thomas Prevot is a Project Scientist and the Vice-President of Operations of Damona Pharmaceuticals TM. He received his PhD in Behavioral Neuropsychopharmacology from the University of Bordeaux in France in 2015, and pursued his career as a Postdoctoral Fellow and Research Scientist in CAMH since 2016.

Dr. Prevot combines a research interest in the neurobiology of memory and emotion processes, and managerial skills to drive the development of Damona Pharmaceuticals TM. Dr. Prevot is actively involved in the translational research and medicine landscape at the University of Toronto, working across disciplines and being an advocate for bench-to-bedside discovery.

Dr. Thomas Prevot is the Vice-President of Operations of Damona PharmaceuticalsTM